Relationship between TNF-α levels and psychiatric symptoms in first-episode drug-naïve patients with schizophrenia before and after risperidone treatment and in chronic patients

par Chen Lin, Ke Chen, Jianjin Yu, Wei Feng, Weihong Fu, Fude Yang, Xiangyang Zhang, Dachun Chen
Publié 2021

Schizophrenia and toxoplasmosis: association with catatonic symptoms

par Dmitry V. Romanov, Aleksey Iu. Brazhnikov, Denis S. Andreyuk, N. V. Zakharova, L. V. Bravve, Vasilisa A. Kovaleva, Evgeniya V. Abbazova, Dmitriy B. Goncharov, Irina V. Titova, Elvira A. Domonova, G. P. Kostyuk
Publié 2020

Clinical Features of First-episode Psychoses During the COVID-19 Pandemic

par Vladimir A. Zyablov, Mikhail A. Gusev, Vasilyi S. Chizhikov
Publié 2021

Affective temperaments of Lebanese patients with schizophrenia: comparison by gender and severity of psychosis

par Joseph E. Dib, Ilige Nehme, Chadia Haddad, Jocelyne Azar, Souheil Hallit, Sahar Obeid
Publié 2021

Safety and efficacy of paliperidone extended-release in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study

par Zhang H, Li H, Liu Y, Wu C, Wu Q, Nuamah I, Shi J, Xie S, Wang G, Gopal S
Publié 2016

Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study

par Zhao JP, Li LH, Shi JG, Li Y, Xu XF, Li KQ, Zhang LL, Cai SL, Feng Y, Zhuo JM, Liu WH, Lu HF
Publié 2017

Association study of the excitatory amino acid transporter 2 (EAAT2) and glycine transporter 1 (GlyT1) gene polymorphism with schizophrenia in a Polish population

par Merk W, Kucia K, Mędrala T, Kowalczyk M, Owczarek A, Kowalski J
Publié 2019